s-1-(combination) has been researched along with Mediastinal-Neoplasms* in 2 studies
2 other study(ies) available for s-1-(combination) and Mediastinal-Neoplasms
| Article | Year |
|---|---|
Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.
We present the case of a 77-year-old Japanese man diagnosed with lung squamous cell carcinoma with mediastinal lymph node metastasis. He was treated with induction chemoradiotherapy for T1bN2M0 stage IIIA disease. Considering his age, we selected S-1 as the chemotherapeutic drug. Observing an objective response with no severe adverse events, we performed a left upper lobectomy with sleeve resection of the pulmonary artery. No residual tumor cells were found in the resected specimens, and no critical complication was observed in the clinical course. This case suggests that induction chemoradiotherapy using S-1 combined with concurrent radiation followed by surgery can be a therapeutic option for elderly patients with locally advanced non-small-cell lung cancer. Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Combinations; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Oxonic Acid; Pneumonectomy; Tegafur | 2016 |
Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Drug Combinations; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Oxonic Acid; Tegafur; Tomography, X-Ray Computed | 2007 |